Stay updated with breaking news from Johnm climaco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) CEO John M. Climaco acquired 15,000 shares of the stock in a transaction dated Wednesday, April 12th. The stock was acquired at an average cost of $0.69 per share, with a total value of $10,350.00. Following the purchase, the chief executive officer now owns 45,010 shares of the […] ....